ArticleOncotarget2015

A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma.

Shan-Shan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.